As of 2026-10-08, the Intrinsic Value of Anavex Life Sciences Corp (AVXL) is -2.16 USD. This Anavex valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.53 USD, the upside of Anavex Life Sciences Corp is -240.87%.
Based on its market price of 1.53 USD and our intrinsic valuation, Anavex Life Sciences Corp (AVXL) is overvalued by 240.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.16 - -2.16 | -2.16 | -240.87% |
| P/E | (11.04) - (12.54) | (11.85) | -874.8% |
| DDM - Stable | (2.93) - (12.62) | (7.78) | -608.3% |
| DDM - Multi | (2.91) - (10.41) | (4.63) | -402.3% |
| Market Cap (mil) | 141.79 |
| Beta | 3.37 |
| Outstanding shares (mil) | 92.67 |
| Enterprise Value (mil) | 23.46 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.68% |
| Cost of Debt | 5.00% |
| WACC | 7.84% |